KR20090100407A - 비천연 아미노산 및 폴리펩티드를 함유하는 조성물, 비천연 아미노산 및 폴리펩티드를 포함하는 방법, 및 비천연 아미노산 및 폴리펩티드의 용도 - Google Patents
비천연 아미노산 및 폴리펩티드를 함유하는 조성물, 비천연 아미노산 및 폴리펩티드를 포함하는 방법, 및 비천연 아미노산 및 폴리펩티드의 용도 Download PDFInfo
- Publication number
- KR20090100407A KR20090100407A KR1020097014780A KR20097014780A KR20090100407A KR 20090100407 A KR20090100407 A KR 20090100407A KR 1020097014780 A KR1020097014780 A KR 1020097014780A KR 20097014780 A KR20097014780 A KR 20097014780A KR 20090100407 A KR20090100407 A KR 20090100407A
- Authority
- KR
- South Korea
- Prior art keywords
- substituted
- alkylene
- alkyl
- amino acids
- natural amino
- Prior art date
Links
- 0 CCC(*)(C(*(C)(C1*2C)*1C(C=CC(C1)=C)=C1*(C)(*)c1c2c(c(*)c(*)c(*)c2*)c2[n]1)=O)N* Chemical compound CCC(*)(C(*(C)(C1*2C)*1C(C=CC(C1)=C)=C1*(C)(*)c1c2c(c(*)c(*)c(*)c2*)c2[n]1)=O)N* 0.000 description 21
- PVSCJJXTUPNEMI-SNAWJCMRSA-N C/C=C/C(Cc1cc(C)c(CC(C2)O)c2c1)C(O)[O]=C Chemical compound C/C=C/C(Cc1cc(C)c(CC(C2)O)c2c1)C(O)[O]=C PVSCJJXTUPNEMI-SNAWJCMRSA-N 0.000 description 1
- RTBBDXIBGADGND-UHFFFAOYSA-N C=NC(C(Cc(cc1)ccc1-c1c[nH]c2ccccc12)N)=O Chemical compound C=NC(C(Cc(cc1)ccc1-c1c[nH]c2ccccc12)N)=O RTBBDXIBGADGND-UHFFFAOYSA-N 0.000 description 1
- GYANMDAYCYGGSC-UHFFFAOYSA-N CC(C)c1ccccc1C(c1c(C2F)ccc(CC(C(O)=[O]=C)N)c1)=C2N Chemical compound CC(C)c1ccccc1C(c1c(C2F)ccc(CC(C(O)=[O]=C)N)c1)=C2N GYANMDAYCYGGSC-UHFFFAOYSA-N 0.000 description 1
- GGKFRLHNQCXKOC-UHFFFAOYSA-O CC(C1)c2cc(CC(C(O)=O)[NH3+])ccc2CC1=O Chemical compound CC(C1)c2cc(CC(C(O)=O)[NH3+])ccc2CC1=O GGKFRLHNQCXKOC-UHFFFAOYSA-O 0.000 description 1
- IUISASZFKWVPCO-UHFFFAOYSA-O CC(COc1c(C)cc(CC(CC=[IH])C([OH2+])=O)cc1)=O Chemical compound CC(COc1c(C)cc(CC(CC=[IH])C([OH2+])=O)cc1)=O IUISASZFKWVPCO-UHFFFAOYSA-O 0.000 description 1
- KQFUQXRQHLVBCW-UHFFFAOYSA-N CC(Cc1ccc(CC(C2N)=O)c2c1)C([O+]=C)=O Chemical compound CC(Cc1ccc(CC(C2N)=O)c2c1)C([O+]=C)=O KQFUQXRQHLVBCW-UHFFFAOYSA-N 0.000 description 1
- CFULIMBOEOPHOM-UHFFFAOYSA-N Cc1c(CC(C2)=O)c2cc(CC(C(O)=O)N)c1 Chemical compound Cc1c(CC(C2)=O)c2cc(CC(C(O)=O)N)c1 CFULIMBOEOPHOM-UHFFFAOYSA-N 0.000 description 1
- WASRMHWDTPAYNF-UHFFFAOYSA-N NC(Cc(cc(CC1=C(C2)C(C3)C3c3c1cccc3)c2c1)c1[O]=N)C(O)=O Chemical compound NC(Cc(cc(CC1=C(C2)C(C3)C3c3c1cccc3)c2c1)c1[O]=N)C(O)=O WASRMHWDTPAYNF-UHFFFAOYSA-N 0.000 description 1
- ROVOGDWZZALYKV-UHFFFAOYSA-N NC(Cc(cc1C2)c(cccc3)c3c1-c1c2[nH]c2ccccc12)C(O)=O Chemical compound NC(Cc(cc1C2)c(cccc3)c3c1-c1c2[nH]c2ccccc12)C(O)=O ROVOGDWZZALYKV-UHFFFAOYSA-N 0.000 description 1
- NAQLWWFLXTZJSF-UHFFFAOYSA-N NC(Cc1c(cccc2)c2c(CC(C2)=O)c2c1)C(O)=O Chemical compound NC(Cc1c(cccc2)c2c(CC(C2)=O)c2c1)C(O)=O NAQLWWFLXTZJSF-UHFFFAOYSA-N 0.000 description 1
- MYPFFKBENNUMPJ-UHFFFAOYSA-N NC(Cc1cc(CC(C2)=O)c2c(O)c1)C(O)=O Chemical compound NC(Cc1cc(CC(C2)=O)c2c(O)c1)C(O)=O MYPFFKBENNUMPJ-UHFFFAOYSA-N 0.000 description 1
- ZASJTUVIXHJKJR-UHFFFAOYSA-N NC(Cc1ccc(CC(CC2)=O)c2c1)C(O)=O Chemical compound NC(Cc1ccc(CC(CC2)=O)c2c1)C(O)=O ZASJTUVIXHJKJR-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87059406P | 2006-12-18 | 2006-12-18 | |
US60/870,594 | 2006-12-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20090100407A true KR20090100407A (ko) | 2009-09-23 |
Family
ID=39536734
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020097014780A KR20090100407A (ko) | 2006-12-18 | 2007-12-18 | 비천연 아미노산 및 폴리펩티드를 함유하는 조성물, 비천연 아미노산 및 폴리펩티드를 포함하는 방법, 및 비천연 아미노산 및 폴리펩티드의 용도 |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP2079687A1 (es) |
JP (1) | JP2010512800A (es) |
KR (1) | KR20090100407A (es) |
CN (1) | CN101578264A (es) |
AU (1) | AU2007333737A1 (es) |
CA (1) | CA2672205A1 (es) |
MX (1) | MX2009006617A (es) |
WO (2) | WO2008077079A1 (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8609383B2 (en) * | 2008-12-10 | 2013-12-17 | The Scripps Research Institute | Production of carrier-peptide conjugates using chemically reactive unnatural amino acids |
US9238878B2 (en) | 2009-02-17 | 2016-01-19 | Redwood Bioscience, Inc. | Aldehyde-tagged protein-based drug carriers and methods of use |
EP4302783A3 (en) * | 2010-08-17 | 2024-03-13 | Ambrx, Inc. | Modified relaxin polypeptides and their uses |
US9567386B2 (en) | 2010-08-17 | 2017-02-14 | Ambrx, Inc. | Therapeutic uses of modified relaxin polypeptides |
JP6162606B2 (ja) | 2011-01-14 | 2017-07-12 | レッドウッド バイオサイエンス, インコーポレイテッド | アルデヒド−タグ付き免疫グロブリンポリペプチド及びその使用方法 |
US20150018530A1 (en) * | 2012-02-29 | 2015-01-15 | Ambrx, Inc. | Novel Prodrug Containing Molecule Compositions and Their Uses |
CN104245720A (zh) * | 2012-02-29 | 2014-12-24 | Ambrx公司 | 白细胞介素-3多肽结合物和其用途 |
US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
US10800856B2 (en) * | 2012-06-07 | 2020-10-13 | Ambrx, Inc. | Prostate-specific membrane antigen antibody drug conjugates |
SG11201408494UA (en) * | 2012-06-19 | 2015-02-27 | Ambrx Inc | Anti-cd70 antibody drug conjugates |
WO2014153164A1 (en) | 2013-03-14 | 2014-09-25 | The California Institute For Biomedical Research | Targeting agent antibody conjugates and uses thereof |
CA2905242C (en) | 2013-03-15 | 2016-11-29 | Pfizer Inc. | Indole compounds that activate ampk |
CA2927543C (en) | 2013-10-15 | 2021-07-20 | The California Institute For Biomedical Research | Peptidic chimeric antigen receptor t cell switches and uses thereof |
US10800828B2 (en) | 2015-03-26 | 2020-10-13 | The Scripps Research Institute | Switchable non-scFv chimeric receptors, switches, and methods of use thereof to treat cancer |
WO2016168773A2 (en) | 2015-04-15 | 2016-10-20 | The California Institute For Biomedical Research | Optimized pne-based chimeric receptor t cell switches and uses thereof |
EP3448885A4 (en) | 2016-04-26 | 2020-01-08 | R.P. Scherer Technologies, LLC | ANTIBODY CONJUGATES AND METHODS OF MAKING AND USING SAME |
CA3040343A1 (en) | 2016-10-19 | 2018-04-26 | California Institute For Biomedical Research | Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof |
TW201837051A (zh) | 2017-02-08 | 2018-10-16 | 美商必治妥美雅史谷比公司 | 包含藥物動力學增強劑之經修飾之鬆弛素(relaxin)多肽及其用途 |
WO2020228734A1 (en) * | 2019-05-13 | 2020-11-19 | Shanghai Polaris Biology Co., Ltd. | A tag for labeling biomolecules |
CN114524934B (zh) * | 2020-11-23 | 2024-01-30 | 华东理工大学 | 多肽聚合物或多肽模拟物在骨修复中的应用 |
AU2022306337A1 (en) * | 2021-07-07 | 2024-02-01 | Ajinomoto Co., Inc. | Method for secretory production of unnatural-amino-acid-containing protein |
WO2024077277A1 (en) | 2022-10-07 | 2024-04-11 | Ambrx, Inc. | Drug linkers and antibody conjugates thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX9709875A (es) * | 1995-06-06 | 1998-03-31 | Pfizer | N-(indol-2-carbonil)-glicinamidas substituidas y derivados como inhibidores de glicogeno fosforilasa, composiciones que las contienen y uso de las mismas. |
US6214790B1 (en) * | 1998-04-10 | 2001-04-10 | Mayo Foundation For Medical Education And Research | Neo-tryptophan |
US6858577B1 (en) * | 1999-06-29 | 2005-02-22 | Ortho-Mcneil Pharmaceutical, Inc. | Indole peptidomimetics as thrombin receptor antagonists |
AU2001260661A1 (en) * | 2000-05-30 | 2001-12-11 | Chugai Seiyaku Kabushiki Kaisha | Compounds exhibiting thrombopoietin-like activities |
MXPA04003758A (es) * | 2001-10-22 | 2005-06-20 | Univ New York State Res Found | Inhibidores de proteina - cinasas y proteina-fosfatasas, metodos para disenarlos y metodos para usarlos. |
-
2007
- 2007-12-18 CA CA002672205A patent/CA2672205A1/en not_active Abandoned
- 2007-12-18 WO PCT/US2007/088011 patent/WO2008077079A1/en active Application Filing
- 2007-12-18 CN CNA2007800469737A patent/CN101578264A/zh active Pending
- 2007-12-18 EP EP07869463A patent/EP2079687A1/en not_active Withdrawn
- 2007-12-18 WO PCT/US2007/088009 patent/WO2011028195A2/en active Application Filing
- 2007-12-18 AU AU2007333737A patent/AU2007333737A1/en not_active Abandoned
- 2007-12-18 KR KR1020097014780A patent/KR20090100407A/ko not_active Application Discontinuation
- 2007-12-18 JP JP2009543156A patent/JP2010512800A/ja active Pending
- 2007-12-18 MX MX2009006617A patent/MX2009006617A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MX2009006617A (es) | 2009-07-24 |
EP2079687A1 (en) | 2009-07-22 |
WO2011028195A2 (en) | 2011-03-10 |
CN101578264A (zh) | 2009-11-11 |
JP2010512800A (ja) | 2010-04-30 |
CA2672205A1 (en) | 2008-06-26 |
WO2011028195A3 (en) | 2011-06-16 |
AU2007333737A1 (en) | 2008-06-26 |
WO2008077079A1 (en) | 2008-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20090100407A (ko) | 비천연 아미노산 및 폴리펩티드를 함유하는 조성물, 비천연 아미노산 및 폴리펩티드를 포함하는 방법, 및 비천연 아미노산 및 폴리펩티드의 용도 | |
JP5425398B2 (ja) | 非天然アミノ酸及びポリペプチドを含む組成物、非天然アミノ酸及びポリペプチドに関連する方法並び非天然アミノ酸及びポリペプチドその使用 | |
KR20090102838A (ko) | 페나진 및 퀴녹살린 치환된 아미노산 및 폴리펩티드 | |
JP2009522275A (ja) | 非天然アミノ酸およびポリペプチドを含んでいる組成物、それらに関する方法、ならびに、それらの使用 | |
KR20080075188A (ko) | 비-천연 아미노산 및 폴리펩티드를 함유하는 조성물,비-천연 아미노산 및 폴리펩티드를 포함하는 방법, 및비-천연 아미노산 및 폴리펩티드의 용도 | |
CN108047086B (zh) | 含有非天然氨基酸和多肽的组合物、涉及非天然氨基酸和多肽的方法以及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |